title: Update in lung cancer and mesothelioma 2012.
authors.affiliation: Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. charles.powell@mssm.edu
authors.forename: Charles A
authors.initials: CA
authors.lastname: Powell
authors.forename: Balazs
authors.initials: B
authors.lastname: Halmos
authors.forename: Serge P
authors.initials: SP
authors.lastname: Nana-Sinkam
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D015897:Comorbidity; D066246:ErbB Receptors / Q000502:physiology; D055106:Genome-Wide Association Study; D054624:Health Status Disparities; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control / Q000601:surgery; D008403:Mass Screening; D008654:Mesothelioma / Q000453:epidemiology / Q000601:surgery; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics
chemical_list: D011518:Proto-Oncogene Proteins; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; C062333:ROS1 protein, human